PPP3CB anticorps (C-Term)
Aperçu rapide pour PPP3CB anticorps (C-Term) (ABIN2217516)
Antigène
Voir toutes PPP3CB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- CALNA2, CT (Calmodulin-dependent Calcineurin A Subunit, beta Isoform, Serine/Threonine Protein Phosphatase 2B Catalytic Subunit, beta Isoform, CAM-PRP Catalytic Subunit, PPP3CB, CNA2)
-
Purification
- Purified by ammonium sulfate precipitation.
-
Immunogène
- Synthetic peptide selected from the C-terminal region of human PPP3CB (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- PPP3CB (Protein Phosphatase 3, Catalytic Subunit, beta Isozyme (PPP3CB))
-
Autre désignation
- CALNA2
-
NCBI Accession
- NP_066955
-
UniProt
- P16298
-
Pathways
- Signalisation RTK, Signalisation WNT, Fc-epsilon Receptor Signaling Pathway, Positive Regulation of Peptide Hormone Secretion, Regulation of Leukocyte Mediated Immunity, VEGF Signaling, BCR Signaling
Antigène
-